From Breakthrough To Blockbuster: The Business Of Biotechnology-new

From Breakthrough To Blockbuster: The Business Of Biotechnology-new

In Stock
SKU: DADAX0195084004
Brand: Ergodebooks
$44.53 $63.61
Save $19.08
Quantity
Add to wishlist
Add to compare

Processing time: 1-3 days

US Orders Ships in: 3-5 days

International Orders Ships in: 8-12 days

Return Policy: 15-days return on defective items

Payment Option
Payment Methods

Help

If you have any questions, you are always welcome to contact us. We'll get back to you as soon as possible, withing 24 hours on weekdays.

Customer service

All questions about your order, return and delivery must be sent to our customer service team by e-mail at yourstore@yourdomain.com

Sale & Press

If you are interested in selling our products, need more information about our brand or wish to make a collaboration, please contact us at press@yourdomain.com

Financial Times Business Top Title March 2022How Could A Large Collection Of Small Companies, Most With Fewer Than 50 Employees, Rise To Compete With Big Pharma, One Of The Worlds Most Breathtakingly Expensive And Highly Regulated Industries?Beginning In The 1970S, Several Scientific Breakthroughs Promised To Transform The Creation Of New Medicines. As Investors Sought To Capitalize On These Nobel Prizewinning Discoveries, The Biotech Industry Grew To Thousands Of Small Companies Around The World. Each Sought To Emulate What The Major Pharmaceutical Companies Had Been Doing For A Century Or More, But Without The Advantages Of Scale, Scope, Experience, And Massive Resources.Biotech Companies Have Met The Challenge By Creating Nearly 40% More Of The Most Important Treatments For Previously Unmet Medical Needs. Moreover, They Have Done So With Much Lower Overall Costs.From Breakthrough To Blockbuster: The Business Of Biotechnology Focuses On Both The Companies Themselves And The Broader Biotech Ecosystem That Supports Them. It Paints A Portrait Of The Crucial Roles Played By Academic Research, Venture Capital, Contract Research Organizations, The Capital Markets, And Pharmaceutical Companies, Demonstrating How A Supportive Environment Enabled The Entrepreneurial Biotech Industry To Create Novel Medicines With Unprecedented Efficiency. In Doing So, It Also Offers Insights For Any Industry Seeking To Innovate In Uncertain And Ambiguous Conditions.

⚠️ WARNING (California Proposition 65):

This product may contain chemicals known to the State of California to cause cancer, birth defects, or other reproductive harm.

For more information, please visit www.P65Warnings.ca.gov.

Recently Viewed